LRI Investments’s Soleno Therapeutics SLNO Stock Holding History

LRI Investments’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-15	Closed	-$502	–	2000
2026 Q1	$502	Buy	+15	New	+$588	﹤0.01%	1373

LRI Investments's SLNO Position: Q2 2026 in Review

LRI Investments sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 15 shares — an estimated $502 sold.

LRI Investments first reported a position in SLNO in Q1 2026 and held it in 1 quarter. The position peaked at $502 in Q1 2026. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

LRI Investments reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
LRI Investments sold 15 Soleno Therapeutics shares in Q2 2026, an estimated $502.
LRI Investments first reported a position in Soleno Therapeutics in Q1 2026 and held it in 1 quarter.
LRI Investments's Soleno Therapeutics position peaked at $502 in Q1 2026.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on LRI Investments's 13F filing for Q2 2026, filed 14 Jul 2026.